Dr. Salman K. Bhatti, MD

Dr. Bhatti practices at Excela Latrobe Hospital in Latrobe, Pennsylvania.

Dr. Bhatti's NPI, 1003140484, was assigned on October 1, 2009. Dr. Bhatti holds Pennsylvania license MD477543.

Dr. Bhatti's primary practice is Excela Latrobe Hospital, at 121 W 2nd Ave, Latrobe, PA 15650 in Westmoreland County. The practice phone is (724) 537-1000.

Dr. Bhatti's primary practice is Excela Latrobe Hospital in Latrobe, Pennsylvania. Dr. Bhatti is also affiliated with Independence Health System Latrobe Hospital. The medical group on file is University of Pittsburgh Physicians, Department of Radiology. Dmand AI also links Dr. Bhatti to 3 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bhatti practices, 6 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Bhatti's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Bhatti is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Bhatti's licenses on file in 3 states: Pennsylvania, Illinois and Ohio.

CMS data shows 968 Medicare services from Dr. Bhatti across 11 procedure codes in 2024, for 631 Medicare patients. Medicare paid $40,097 for them.

CMS counts 631 Medicare patients who saw Dr. Bhatti in 2024. The largest group is 65 to 74, with 268 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 2.16, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bhatti's median patient age at 75, with 52% women.

In 2024, Dr. Bhatti wrote 1,541 Medicare Part D claims for 304 patients. 83% of them were for generic drugs. CMS names the drug for 1,442 of them, across 26 drugs with 11 or more claims each, at $267,409 in total drug cost. In 2023, CMS named 1,161 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Bhatti for performance year 2024, reported as part of a group. Dr. Bhatti accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 12 papers to Dr. Bhatti, published from 2011 to 2021. 2013 was the busiest year, with 3. The most frequent topics are Cardiovascular Diseases, Atrial Fibrillation and Blood Pressure. Dr. Bhatti has published most often in J Am Coll Cardiol. Dr. Bhatti's most frequent co-authors are Carl J. Lavie, MD, Adnan Khalid, MD and Harshal Rohidas Patil, MD.

CMS Open Payments shows 32 general payments to Dr. Bhatti from 5 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 72% of the total. Abbott Laboratories paid the most, $2,907.